is the only FDA-approved medication for people with primary progressive MS (PPMS) and RRMS. If you’re not comfortable with needles, there are oral options for treating MS. Oral medications are ...

You disconnect your cell phone from its charger as you get ready for a busy day. But even though it has been connected all night, the battery is only partially charged. You look at ...

On the other hand, two studies of the drug in relapsing forms of MS ... A fourth phase 3 trial called PERSEUS in patients with primary progressive MS (PPMS) is still ongoing, with results ...

On average, primary progressive multiple sclerosis causes severe disability ... researchers have been unable to develop effective treatments. Currently, the only FDA-approved drug helps slow ...

Elevated liver enzymes have also been seen with other BTK drugs, and Sanofi said that ... 3 trial called PERSEUS in patients with primary progressive MS (PPMS). Earlier this year, it abandoned ...

The most common question is about what type of MS do I have. So we'll go online, and I'll see this relapsing, remitting, and primary progressive ... All of the medications we have right now ...

Ocrelizumab significantly reduced the number and volume of cortical lesions associated with multiple sclerosis at 120 weeks, ...

In people with primary progressive multiple sclerosis (MS), a new study has found no difference in the amount of time before ...

That's because the primary progressive ... treatments that mesh with those goals at all stages of the disease. Together, you ...

A number of disease-modifying drugs ... progressive multifocal leukoencephalopathy, a deadly opportunistic virus infection of the CNS, so far no case has been identified in MS patients receiving ...

Commonly, progressive atrophy is the main feature of secondary progressive MS on brain MRI ... or immunomodulatory drug within 6 months of study entry. The primary outcome examined was the ...